Connect with us

Business

Zydus, Sunshine launch US$20 million pharma plant in Horana to boost local drug manufacturing

Published

on

Leadership teams of Zydus Lifesciences Ltd and Sunshine Holdings PLC at the official foundation stone laying ceremony

A market-driven investment backed by confidence in local pharmaceutical manufacturing

Sri Lanka’s drive to strengthen domestic pharmaceutical manufacturing received a major boost last week with the launch of a US$20 million joint venture between India’s Zydus Lifesciences and Sri Lanka’s Sunshine Healthcare to establish a modern pharmaceutical manufacturing facility at the Board of Investment (BOI) zone in Horana.

The foundation stone for the new plant, to be built on nearly four acres, was laid by the leadership of the two companies in the presence of senior executives and stakeholders. The facility will manufacture pharmaceutical products for the local retail market, helping improve the availability of quality medicines while reducing Sri Lanka’s dependence on imports.

The venture, operating as Zydus Sunshine Lifesciences Pvt. Ltd., combines Zydus’ global pharmaceutical manufacturing expertise with Sunshine Healthcare’s extensive distribution network and strong presence in Sri Lanka’s healthcare sector. The project is expected to facilitate technology transfer, create skilled employment, and strengthen the country’s healthcare supply chain.

Speaking at the ceremony, Dr. Sharvil P. Patel, Managing Director of Zydus Lifesciences, said the investment reflected the company’s long-standing commitment to Sri Lanka, where it has operated for more than three decades.

“We have always believed that strong local capabilities are key to resilient healthcare ecosystems,” he said. “Through Zydus Sunshine Lifesciences, we seek to contribute to the development of a stronger pharmaceutical manufacturing base in Sri Lanka by combining global scientific expertise with deep local execution capabilities.”

Dr. Patel added that the project would go beyond manufacturing by creating high-quality employment opportunities across science, technology, healthcare and operations, helping nurture the next generation of talent in Sri Lanka’s pharmaceutical industry.

Sunshine Holdings Deputy Chairman Vish Govindasamy described the venture as a significant progression in Sri Lanka’s future at a time when countries are seeking to secure stable supply chains.

“The establishment of Zydus Sunshine Lifesciences contributes directly to building greater pharmaceutical security for Sri Lanka,” he said. “Together, we are combining global knowledge with local capability to strengthen pharmaceutical manufacturing, healthcare resilience and our commitment to serving the Sri Lankan people.”

Govindasamy noted that the project represents the largest foreign direct investment into Sri Lanka’s pharmaceutical manufacturing sector to date, with the initial equity capital of US$10 million contributed equally by the two partners. Sunshine Healthcare’s participation has been supported by the International Finance Corporation’s US$11 million equity investment made last year to support the company’s growth strategy.

The new manufacturing facility will operate under the oversight of the BOI, with the Ministry of Health and the National Medicines Regulatory Authority providing regulatory supervision. All products manufactured at the plant will comply with NMRA standards and applicable pricing regulations.

The investment comes as Sri Lanka continues efforts to expand local production of essential medicines following recent economic challenges that exposed vulnerabilities in import-dependent supply chains. By increasing domestic manufacturing capacity, the partners expect the project to improve medicine availability, strengthen supply security and support the country’s broader healthcare resilience while generating high-value employment and industrial growth.

The foundation stone ceremony marked the formal commencement of construction, with both partners expressing confidence that the venture would play a meaningful role in advancing Sri Lanka’s long-term healthcare and manufacturing ambitions.

Unlike many local pharmaceutical manufacturers that operate under government buy-back agreements guaranteeing sales to the public health system, Zydus Sunshine Lifesciences will initially rely entirely on Sri Lanka’s private healthcare market. The partners are betting that locally manufactured, high-quality medicines can successfully replace imported products, making the venture commercially viable without state purchase guarantees. However, Sunshine Holdings Deputy Chairman Vish Govindasamy told The Island Financial Review that the company would welcome opportunities to supply the government sector as well, should the authorities choose to procure its products in the future.

By Sanath Nanayakkare



Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

Lanka Hospitals celebrates 2025 milestones at Pulse of Excellence Awards

Published

on

Lanka Hospitals Corporation PLC successfully hosts its exclusive "Pulse of Excellence" awards ceremony recently

The Lanka Hospitals Corporation PLC successfully hosted its exclusive “Pulse of Excellence” awards ceremony recently. The event was organized to recognize and celebrate the institution’s remarkable milestone achievements and outstanding overall performance in 2025.

The ceremony was graced by Dr. Nalinda Jayatissa, Minister of Health and Mass Media and Chief Government Whip, who attended as the Chief Guest and delivered a special address. During his address, the Minister highlighted the institution’s profound contribution to the country, stating: “These achievements are now an integral part of the hospital’s enduring legacy and a testament to its vital role within our nation’s healthcare sector. Lanka Hospitals has consistently demonstrated that true medical excellence is achieved when world-class clinical standards are driven by a genuine, compassionate duty of care toward the people.”

Other distinguished dignitaries in attendance included Dr. Hansaka Wijayamuni, Deputy Minister of Health, and Dr. Priyantha Tennakoon, Director of Private Health Sector Development.

The evening highlighted Lanka Hospitals’ continued commitment to shaping the future of healthcare through a comprehensive awards program, with accolades distributed across several key categories. In the area of Financial and Operational Excellence, departments such as Cardiology, Bariatric Surgery, Neurosciences, Out-Patient, and Radiology were recognized for record-breaking performances in 2025. Notably, the Neurosciences department was commended for achieving the highest number of advanced neurosurgical procedures during the year.

Furthermore, National and International Excellence Awards were presented to the Departments of Finance, Quality Assurance, Infection Prevention and Control, and Marketing. A significant highlight in this category was the hospital’s prestigious nomination by the World Health Organization (WHO) as the first private mentor hospital for Antimicrobial Stewardship in Sri Lanka.

The ceremony also celebrated leadership and dedication. A highly anticipated Lifetime Service Excellence Award was presented to Mr. Sunil Gamage, Chief Ward Master, in recognition of his enduring commitment and service. Additionally, special recognition was bestowed upon Lanka Hospitals Diagnostics (Pvt) Ltd. in honor of its outstanding service excellence and exceptional financial performance throughout the year.

A major milestone of the evening was the official launch of the LHD Mobile Laboratory Service, which was ceremonially inaugurated during the event.

Continue Reading

Business

Ceylon Green Life Plantation expands internationally with Malaysia greenhouse venture

Published

on

The initial phase of the project will be carried out on a fifty-acre land allocation

Ceylon Green Life Plantation (CGLP) has marked a significant milestone in its growth journey by launching its first international agricultural venture in Malaysia, reinforcing its commitment to modern, sustainable farming and global market expansion. The company recently announced the commencement of a large-scale greenhouse cultivation project in Malaysia, which is expected to create new opportunities for Sri Lankan agricultural expertise while strengthening regional agricultural collaboration.

Implemented with the support of the Malaysian Government, the initial phase of the project will be carried out on a fifty-acre land allocation. The venture will utilise advanced greenhouse technology, modern cultivation methods and high-yield seed varieties to produce vegetables tailored to the demands of the Malaysian market.

CGLP Founder and Chairman Dr. Malan Francis Peter said the initiative represents a major step towards positioning Sri Lankan agricultural knowledge and expertise on the international stage. “This project provides access to advanced agricultural technologies, improved cultivation practices and a ready market for produce. It creates opportunities not only for our organisation but also for Sri Lankan farmers and agricultural professionals who can benefit from international exposure and knowledge transfer,” he said.

Continue Reading

Business

ComBank Visa cardholders rewarded with FIFA World Cup Final journey

Published

on

One of the winners of an all-expenses-paid visit to the FIFA World Cup final with Sanath Manatunge, Managing Director/CEO of Commercial Bank and Avanthi Colombage, Visa Country Manager for Sri Lanka and the Maldives, and senior representatives of the two organisations.

The Commercial Bank of Ceylon, in collaboration with Visa, has rewarded two of its credit cardholders with an extraordinary opportunity to witness the Final of the FIFA World Cup 2026 in the United States, one of the most coveted events in global sport.

Selected through a special spend drive conducted exclusively for Commercial Bank Visa Platinum, Signature and Infinite credit card holders, the two winners will each travel with a companion to attend the Final match scheduled for 19th July 2026 at the MetLife Stadium in East Rutherford, New Jersey.

The campaign considered card spending between 15th March and 10th May 2026, culminating in a draw that identified the two fortunate winners. Each winner will receive two tickets to the FIFA World Cup Final, return business class air tickets to the USA, and a fully paid four-night tour package for two, including luxury accommodation and transfers.

The official prize presentation ceremony was held at the Head Office of Commercial Bank, where the winners were felicitated by the Bank’s senior management together with regional leadership representatives from Visa.

Continue Reading

Trending